İdiopatik Hipertrofik Pakimenenjit
Özet
Hipertrofik pakimenenjit, serebral veya spinal dura materin kalınlaşmasıyla karakterize, nadir ve kronik bir inflamatuvar hastalıktır. Enfeksiyöz, otoimmün veya neoplastik nedenlere bağlı gelişebildiği gibi, altta yatan nedenin belirlenemediği durumlarda idiyopatik olarak adlandırılmaktadır. Kronik baş ağrısı ve kraniyal nöropatiler gibi progresif nörolojik belirtilerle seyreden bu hastalığın tanısında MRG ve biyopsi kritik öneme sahiptir. Kesin bir tedavisi bulunmamakla birlikte, steroidler ve bağışıklık sistemini baskılayan tedaviler klinik iyileşme sağlamak amacıyla kullanılmaktadır.
Hypertrophic pachymeningitis is a rare, chronic inflammatory disorder characterized by the thickening of the cerebral or spinal dura mater. It may result from infectious, autoimmune, or neoplastic causes, though it is termed "idiopathic" when the underlying etiology remains unidentified. Clinical presentations often involve progressive neurological deficits, such as chronic headaches and cranial neuropathies, with diagnosis typically relying on MRI and tissue biopsy. While there is no definitive cure, management strategies primarily include steroid therapy and immunosuppressive agents to address symptoms.
Referanslar
Mamelak AN, Kelly WM, Davis RL, Rosenblum ML. Idiopathic hypertrophic cranial pachymeningitis. Report of three cases. J Neurosurg. 1993;79(2):270-6.
Zhao M, Geng T, Qiao L, et al. Idiopathic hypertrophic pachymeningitis: Clinical, laboratory and neuroradiologic features in China. J Clin Neurosci. 2014;21(7):1127-1132.
Melenotte C, Seguier J, Ebbo M, et al. Clinical presentation, treatment and outcome of IgG4-related pachymeningitis: From a national case registry and literature review. Semin Arthritis Rheum. 2019;49(3):430-437.
Yonekawa T, Murai H, Utsuki S, et al. A nationwide survey of hypertrophic pachymeningitis in Japan. J Neurol Neurosurg Psychiatry. 2014;85(7):732-739.
Asano T, Hayashida M, Ogawa K, Adachi K, Teramoto A, Yamamoto M. Hypertrophic cranial pachymeningitis in a patient with aplastic anemia. Ann Hematol. 1998;77(6):279-282
van Toorn R, Esser M, Smit D, Andronikou S. Idiopathic hypertrophic cranial pachymeningitis causing progressive polyneuropathies in a child. Eur J Paediatr Neurol. 2008;12(2):144-147.
Aburahma SK, Anabtawi AG, Al Rimawi HS, Elheis MA, Mohtaseb AH. Idiopathic hypertrophic pachymeningitis in a child with hydrocephalus. Pediatr Neurol. 2009;40(6):457-460.
Karimi A, Tabatabaei SR, Shiva F, et al. Tuberculous pachymeningitis in a young child with spinal involvement: A case report. Arch Pediatr Infect Dis. 2013;1(1):36-39.
Sharma PK, Saikia B, Sharma R, Gagneja V, Khilnani P. Pachymeningitis in a young child responded to antitubercular therapy: A case report. J Child Neurol. 2014;29(10):NP92-NP95.
Tsuchida K, Fukumura S, Yamamoto A, Akiyama Y, Hirano H, Tsutsumi H. Rapidly progressive fatal idiopathic hypertrophic pachymeningitis with brainstem involvement in a child. Child’s Nerv Syst. 2018;34(9):1795-1798.
Matsumoto K, Akiyama M, Kajio N, et al. Adolescent PR3-ANCA-positive hypertrophic pachymeningitis: A case report and review of the literature. Medicine (Baltimore). 2018;97(17): e0521.
Brand B, Somers D, Wittenberg B, Gautreaux J, Deputy S. Diplopia With Dural Fibrotic Thickening. Semin Pediatr Neurol. 2018;26:83-87.
Hsieh DT, Faux BM, Lotze TE. Headache and Hypoglossal Nerve Palsy in a Child With Idiopathic Hypertrophic Pachymeningitis. Headache. 2019;59(8):1390-1391.
Nambirajan A, Sharma MC, Garg K, Sriram S, Boorgula MT, Suri V. Large dural-based mass with bony hyperostosis in a 16-year-old male: IgG4-related disease mimicking lymphoplasmacyte-rich meningioma. Child’s Nerv Syst. 2019;35(8):1423-1427.
Sharawat IK, Saini AG, Vyas S, Sankhyan N. “Encased brain” in hypertrophic pachymeningitis. Child’s Nerv Syst. 2019;35(4):585-587.
Vakrakou AG, Evangelopoulos ME, Boutzios G, et al. Recurrent myelitis and asymptomatic hypophysitis in IgG4-related disease: case-based review. Rheumatol Int. 2020;40(2):337-343.
Wallace ZS, Carruthers MN, Khosroshahi A, et al. IgG4-related disease and hypertrophic pachymeningitis. Med (United States). 2013;92(4):206-216.
Hahn LD, Fulbright R, Baehring JM. Hypertrophic pachymeningitis. J Neurol Sci. 2016;367:278-283.
Riku S, Kato S. Idiopathic hypertrophic pachymeningitis. Neuropathology. 2003;23(4):335-344
Kupersmith MJ, Martin V, Heller G, Shah A, Mitnick HJ. Idiopathic hypertrophic pachymeningitis. Neurology. 2004;62(5):686-94.
AbdelRazek MA, Venna N, Stone JH. IgG4-related disease of the central and peripheral nervous systems. Lancet Neurol. 2018;17(2):183-192.
Kazem IA, Robinette NL, Roosen N, Schaldenbrand MF, Kim JK. Best cases from the AFIP: idiopathic tumefactive hypertrophic pachymeningitis. Radiographics. 2005;25(4):1075-1080
Lee YC, Chueng YC, Hsu SW, Lui CC. Idiopathic hypertrophic cranial pachymeningitis: Case report with 7 years of imaging follow-up. Am J Neuroradiol. 2003;24(1):119-123.
Lam BL, Barrett DA, Glaser JS, Schatz NJ, Brown HH. Visual loss from idiopathic intracranial pachymeningitis. Neurology. 1994;44(4):694-698
Mekinian A, Maisonobe L, Boukari L, et al. Characteristics, outcome and treatments with cranial pachymeningitis: A multicenter French retrospective study of 60 patients. Medicine (Baltimore). 2018;97(30):e11413. Erratum in: Medicine (Baltimore). 2018 Aug;97(33):e12063. PMID: 30045263; PMCID: PMC6078725.
Rizzo E, Ritchie AE, Shivamurthy V, Siddiqui A, Lim M. Idiopathic hypertrophic pachymeningitis: Does earlier treatment improve outcome? Children. 2021;8(1):1-7.
Masson C, Hénin D, Hauw JJ, Rey A, Raverdy P, Masson M. Cranial pachymeningitis of unknown origin: a study of seven cases. Neurology. 1993;43(7):1329-34.
Voller B, Vass K, Wanschitz J, et al. Hypertrophic chronic pachymeningitis as a localized immune process in the craniocervical region. Neurology. 2001;56(1):107-109.
Ashkenazi E, Constantini S, Pappo O, Gomori M, Averbuch-Heller L, Umansky F. Hypertrophic spinal pachymeningitis: report of two cases and review of the literature. Neurosurgery. 1991;28(5):730-2.
Hatano N, Behari S, Nagatani T, et al. Idiopathic hypertrophic cranial pachymeningitis: clinicoradiological spectrum and therapeutic options. Neurosurgery. 1999;45(6):1336-42; discussion 1342-4
Sugiyama Y, Shimizu M, Hoshi A, et al. [An old man presenting with fluctuating bilateral multiple cranial nerve palsies and positive test for perinuclear antineutrophil cytoplasmic antibody]. No To Shinkei. 1999;51(9):825-32. Japanese. PMID: 10511963
Parney IF, Johnson ES, Allen PB. "Idiopathic" cranial hypertrophic pachymeningitis responsive to antituberculous therapy: case report. Neurosurgery. 1997;41(4):965-71
